- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03274089
Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk
A Randomized Controlled Trial to Evaluate the Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk
The chronic disease burden is increasing worldwide leading to a rise in the demand for primary healthcare and a shortage of primary care physicians. Addressing this shortage entails a multi-prong approach with innovations in care delivery, greater use of healthcare technology, and more efficient use of all healthcare providers on the care team.
We previously developed an interactive self-service healthcare kiosk (Self-empowering and enabling kiosk - SEEK® MyHealthKiosk) for the management of patients with stable chronic disease in the primary care setting. A feasibility study using SEEK showed high levels of acceptance and satisfaction from patients and healthcare providers.
The aim of this follow-up study is to evaluate the health outcomes of patients with stable chronic disease who are on kiosk management compared to patients who are on routine management by nurse clinicians. We hypothesize that patients who are managed by the kiosk continue to maintain good disease control that are comparable to patients who are managed by a nurse clinician.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Patients who seek primary healthcare vary in their time and resource requirements. Patients with acute medical conditions or poorly controlled chronic disease typically require more time and attention compared to patients with stable chronic disease.
Patients with chronic disease routinely make follow-up visits to their primary care provider for assessment of their chronic disease status and for changes to their medications as necessary. Patients with well-controlled stable chronic disease may go through several visits to their primary care provider in 3 or 4-monthly intervals with little or no change to their medication regimen. These patients have to wait in line with the rest of the patient crowd for a doctor's consultation before getting their regular supply of medications. We hence saw the potential of replacing some of these physician visits with an automated healthcare kiosk so that if the disease condition of such patients remained stable, they can continue on their current medications without having to see a doctor.
We previously described the feasibility of using an automated healthcare kiosk (SEEK® MyHealthKiosk) for the management of patients with stable chronic disease in the primary care setting. We propose a follow-up study to show equivalence of health outcomes for patients managed with SEEK compared to the current standard of care. The study will be a 2-armed randomized controlled trial of 120 patients with stable chronic disease on 4-monthly follow-up visits over a 12-month period. Patients will be assigned randomly to intervention or control groups to receive kiosk or nurse management respectively. The main primary outcome measure is the overall chronic disease control of the patients. Other primary outcome measures are the blood pressure and low-density lipoprotein cholesterol levels for patients without diabetes; and blood pressure, low-density lipoprotein cholesterol and hemoglobin A1c levels for patients with diabetes. Secondary outcome measures are visit duration, patient satisfaction with the management process, health-related quality of life, and the occurrence of any adverse event.
The potential benefits from the use of SEEK are:
- Appropriate stratification of patient care needs so that more time and resources can be channeled to patients with complex or acute needs;
- Patient empowerment in the management of their chronic health conditions, with flexibility of self-care and monitoring and decreased dependency on healthcare providers;
- Substitution of nurse clinicians for the management of stable chronic disease;
- Reduction in the number of doctor visits per year for patients with stable chronic disease.
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Grace Ng
- Telefoonnummer: +65 6377 8771
- E-mail: grace.ng.b.h@singhealth.com.sg
Studie Contact Back-up
- Naam: Caris Tan
- Telefoonnummer: +65 6377 7107
- E-mail: tan.yang.thong@singhealth.com.sg
Studie Locaties
-
-
-
Singapore, Singapore
- Werving
- SingHealth Polyclinics - Punggol
-
Contact:
- Executive
- Telefoonnummer: 6643 6969
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- are between the ages of 21 and 75 years
- have at least one chronic medical condition that includes hypertension, hyperlipidemia, diabetes mellitus
- have blood pressure, low-density lipoprotein cholesterol (LDL-C) and HbA1c levels within the recommended targets according to the Ministry of Health Singapore clinical practice guidelines for their current and last follow-up visits
- are able to provide informed consent.
Exclusion Criteria:
- have serum creatinine more than 140 mmol/L (from tests done within the past year)
- have serum potassium less than 3.5 mmol/L or more than 5 mmol/L (from tests done within the past year)
- have overt proteinuria (urine protein:creatinine ratio more than 0.5)
- were discharged from hospital or specialist follow-up within the last 6 months
- have any pending laboratory or investigation result
- are scheduled for any laboratory investigation within the next 4 months (except HbA1c or panel test)
- have any new complaint related to their chronic medical conditions
- have a known history of white coat hypertension
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Kiosk intervention group
|
SEEK automates the management of patients with stable well-controlled chronic disease. SEEK has the following capabilities:
Andere namen:
|
Geen tussenkomst: Nurse clinician control group
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
Bloeddruk
Tijdsspanne: 12 maanden
|
12 maanden
|
Hemoglobine a1c
Tijdsspanne: 12 maanden
|
12 maanden
|
Disease control
Tijdsspanne: 12 months
|
12 months
|
Low-density lipoprotein cholesterol
Tijdsspanne: 12 months
|
12 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Bijwerkingen
Tijdsspanne: 12 maanden
|
12 maanden
|
|
Visit duration
Tijdsspanne: 8 months
|
8 months
|
|
Patient satisfaction questionnaire
Tijdsspanne: 12 months
|
The following areas of patient satisfaction will be scored on a Likert scale: convenience of visit schedule, location of kiosk or nurse consultation, appropriateness of management, duration of time spent in kiosk usage or nurse consultation, and the replacement of a doctor's visit by the kiosk or nurse clinician.
Qualitative feedback will be captured via free-text inputs.
|
12 months
|
Health-related quality of life questionnaire
Tijdsspanne: 12 months
|
Health-related quality of life will be assessed using the EQ-5D-5L questionnaire.
|
12 months
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 1629027001
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Kiosk intervention group
-
University of California, San FranciscoVoltooidDarmkanker | EndeldarmkankerVerenigde Staten
-
SpoedopnameVoltooid
-
St. Joseph's Healthcare HamiltonHamilton Academic Health Sciences OrganizationVoltooid
-
Arab American University (Palestine)VoltooidDiabetes mellitus type 2Palestijns gebied, bezet
-
Akdeniz UniversityVoltooidBorstkanker | Gezondheidsgedrag | Vroege detectie van kanker | Kankerscreening | Preventieve gezondheidszorgKalkoen
-
Lawson Health Research InstituteLondon Health Sciences CentreVoltooid
-
University of Colorado, DenverSociety for Adolescent Health & MedicineVoltooid
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...VoltooidSeksueel overdraagbare aandoeningen | Anticonceptie | Reproductief gedrag
-
April M YoungNational Institute on Drug Abuse (NIDA)WervingSeksueel overdraagbare aandoeningen | Aan opioïden gerelateerde aandoeningen | Drugsmisbruik | Overdosis drugs | Opiaatsubstitutiebehandeling | Humaan Immunodeficiëntie Virus (HIV) | Hepatitis C (HCV) | Intraveneus drugsgebruikVerenigde Staten
-
Chinese University of Hong KongActief, niet wervendIntellectuele handicap, MildHongkong